Dodge & Cox grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,384,701 shares of the biopharmaceutical company’s stock after purchasing an additional 161,642 shares during […]
National Pension Service grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 185,174 shares of the biopharmaceutical company’s stock after purchasing an additional 3,386 shares during the period. National Pension Service owned […]
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price objective boosted by Royal Bank of Canada from $820.00 to $830.00 in a research note issued to investors on Monday, MarketBeat.com reports. Royal Bank of Canada currently has a sector perform rating on the biopharmaceutical company’s stock. Several other research analysts also recently weighed in on […]
Cigna Investments Inc. New trimmed its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.0% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,272 shares of the biopharmaceutical company’s stock after selling 26 shares during the quarter. Cigna Investments […]
ExodusPoint Capital Management LP increased its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 67.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,833 shares of the biopharmaceutical company’s stock after acquiring an additional 12,777 shares during […]